Cerenetex – Revolutionizing Large Vessel Occlusion (LVO) ischemic stroke diagnostics.
Cerenetex is at the forefront of revolutionizing the diagnosis of Large Vessel Occlusion (LVO) ischemic strokes.
About Cerenetex:
Our mission is to reduce delays in brain injury care.
Strokes, affecting 15 million individuals globally, are a prominent cause of disability and mortality worldwide. Addressing the current delay in stroke treatment is critical as it often results in misdiagnosis and hinders prompt triage.
Our innovative technology seamlessly integrates with subjective neurological assessments, significantly improving the precision of patient triage and expediting treatment for LVO stroke patients.
Meet the Cerenetex Team
Dr. M. Mohsin Shah, FAAN FACS
Chairman & Chief Executive Officer
Dr. M. Mohsin Shah, board-certified Neurosurgeon and board-eligible Neurologist, specializes in stroke, neurotrauma, and neurocritical care. He has fellowshipped in Neurocritical Care and Interventional Neuroradiology. Dr. Shah is adept at leveraging cost-saving opportunities to expand neuroscience tech.
Brian Tatomir, MBA, Chief Operating Officer, Financial Officer
Brian Tatomir, MBA, is a seasoned Sales and Marketing leader with an extensive background in the medical device industry. Through decades of healthcare expertise, Brian aligns product value with consistent revenue growth. Likewise, he’s adept at managing costs by leveraging a vast network of connections.
Brian Brady, Chief Strategy Officer & Business Development Director
Brian Brady is a driven sales management professional. Over two decades, he’s revitalized underperforming sales teams. He’s known throughout the industry for effective communication and strategic selling. Brian thrives in competitive environments while maximizing retention and delivering key results.
Ben Bobo, CMO &
Board of Advisors
Ben Bobo is a respected senior executive in both business and community leadership. Over 25 years in startups, Ben has developed a vast background in healthcare and neurological innovation.
Tim Hays,
Chief Technical Officer
Tim Hays executes the technical and scientific development of the CereView device. He has over 40 years in software and product development. Tim has a comprehensive knowledge of digital signal processing and artificial intelligence.
About Cerenetex:
Hear from the Cerenetex Team How Our Device is Enabling LVO Ischemic Stroke Detection & Management
